Intern - IT - AI/ML Enterprise Data & Analytics at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without sponsorship now or in the future or CPT/OPT through your University
Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate if necessary and work at the designated site for the duration of the internship
Preferred Qualifications
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment
Alignment with Gilead Core Values: Integrity, Inclusion, Teamwork, Excellence, Accountability

Responsibilities

Collaborate with Agile teams to understand requirements for R&D and PDM/Tech Ops applications
Support research/Development or PDM/Tech Ops data science and advanced analytics use cases, including AI/ML and GenAI projects
Assist in the development, deployment, and integration of scientific and business applications into HPC and cloud environments
Build and maintain data pipelines and ETL processes for large-scale data sets
Conduct data cleaning, transformation, and analysis using statistical and machine learning techniques
Develop data visualizations and dashboards to communicate insights
Integrate Data & Analytics workflows from other platforms with enterprise environments
Contribute to solution documentation and present your work at the end of the internship
Participate in team meetings, professional development events, and community activities
Stay technically current through education and planning
Showcase your work with a final presentation (PPT) near the conclusion of your internship

Skills

GenAI

Data Science

Advanced Analytics

Agile

R&D

PDM

Tech Ops

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free